Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Clinical trial NCT06138613 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06138613
- Sponsor
- Vanda Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2027-09-30
- Enrollment
- 705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.